Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications.
Goldman L, Goldman PA, Williams LW, Weinstein MC. Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications. Am J Cardiol. 1993 Sep 30; 72(10):75D-79D.